EIDE ROBERT J enters MATINAS BIOPHARMA HOLDINGS, INC. with 1.50K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 3/7/2025ACC: 0001477932-25-001559
10% Owner
1.50K
Baseline shares
0.00
Direct ownership
0 positions
2.52M
Derivative underlying
2 instruments
1
Security positions
1.50K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned1.50K
Total
1.50K indirect1.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.50K | Indirect |
| Total | 1.50K | 1.50K indirect |
Derivative Holdings2
Warrants
IndirectUnderlying security
Common Stock
Underlying shares
1.68M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series C Convertible Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
839.59K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
2.52M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants Indirect | Common Stock | — | — | 1.68M | N/A | |
| Series C Convertible Preferred Stock Indirect | Common Stock | — | — | 839.59K | N/A | |
| Total | 2.52M | 0.00 | ||||